mRNA production partnership to scale-up COVID-19 vaccine development
![](/46/pdcnewsitem/11/83/22/2BKCPT2-min_scaled.jpg)
GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site.
Biotech company GreenLight Biosciences based in Boston, USA have announced the first successful completion of a commercial-scale engineering run for their mRNA production partnership with Samsung Biologics, a leading CDMO based in Incheon, South Korea.
The strategic partnership was announced in late 2021, with the goal of transferring technology and scaling-up from a lab bench to commercial facilities provided by Samsung. The process from drug substance and lipid nanoparticle formulation straight through to bulk drug product can now be completed in the same facility. With Samsung’s RNA platform, GreenLight can now progress from conceptualizing an mRNA vaccine to delivering material for clinical trials in less than 2 years, allowing them to supply an mRNA vaccine at a commercial scale.
In early 2022, Samsung Biologics completed the expansion of their mRNA drug substance manufacturing suite at the Songdo headquarters, providing a fully equipped facility for end-to-end mRNA production for their clients.
CEO and President of Samsung Biologics John Rim commented: “This demonstrates a major achievement in our continuing goal to offer one-stop end-to-end mRNA production from drug substance to aseptic fill finish to commercial release, all from a single site as we strive across our biomanufacturing network to fight the pandemic.”
GreenLight CEO Andrey Zarur added: “One of the greatest challenges when producing quality pharmaceuticals is advancing from a small lab to large-scale commercial production… We are grateful for the help and support of Samsung in demonstrating that our small mRNA process can scale in a linear fashion to the industrial scale that will be needed to help satisfy the vaccine needs of humanity.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance